New Zealand's first fatality linked to use of 1,4-butanediol (1,4-B, fantasy): No evidence of coingestion or comorbidity

New Zealand Medical Journal

Volumn 116, Issue 1184, 2003, Pages

  Theron, Lynn ^a   Jansen, Karl L R ^a   Skinner, Adrian M ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BUTANEDIOL; 4 HYDROXYBUTYRIC ACID; ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; DIAMORPHINE; MORPHINE; PSYCHOTROPIC AGENT; 1,4-BUTANEDIOL; BUTANEDIOL;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; AUTOPSY; BRAIN DEATH; BRAIN INJURY; CASE REPORT; DEFIBRILLATION; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG OVERDOSE; HEART ARREST; HUMAN; INTUBATION; MALE; RESUSCITATION; SEIZURE; SHOCK; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; UNCONSCIOUSNESS; URINALYSIS; FATALITY; FEMALE; INTOXICATION;

ADULT; BUTYLENE GLYCOLS; FATAL OUTCOME; FEMALE; HUMANS; MALE; OVERDOSE;

EID: 0642372754     PISSN: 11758716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Zvosec DL, Smith SW, McCutcheon JR, et al. Adverse events, including death, associated with the use of 1,4-butanediol. N Engl J Med 2001;344:87-94.
2. Chin RL, Sporer KA, Cullison B, et al. Clinical course of gamma-hydroxybutyrate overdose. Ann Emerg Med 1998;31:716-22.
3. Jansen KL. Non-medical use of ketamine. BMJ 1993;306:601-2.
4. Anonymous. 1,4-butanediol. Drug Education Trust 2001. (No address supplied. For a copy of this pamphlet contact the author.)
5. Dean W, Morgenthaler J, Fowkes SW. GHB: the natural mood enhancer. Petaluma, CA: Smart Publications; 1998.
6. Fowkes WM. Another case from an incompetent coroner. Smart Life News, 21 January 2001;8:1-20.